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Abstract:  
This review brings together two strands of investigation in the neuropsychology and 
neurophysiology of schizophrenia that have been particularly productive over the last 20 
years. We review the literature on working memory deficits, particularly in the visual 
domain, and changes in oscillatory neural activity as measured with electroencephalography 
(EEG) and magnetoencephalography (MEG). We argue that recent results suggest a link 
between these two phenomena, in that altered oscillations underlie some of the working 
memory deficits. We furthermore argue that early sensory mechanisms contribute more to 
working memory (and other) deficits than previously thought. The final part of our review 
suggests links between working memory, oscillations, and their alterations in schizophrenia 
and the dopamine, GABA, glutamate and acetylcholine system. These links have already 
resulted in the development of new remediation strategies, which have some translational 
potential.  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
4 
 
Introduction 
Schizophrenia is a severe mental disorder affecting approximately 1% of the population with 
an equal gender distribution. The typical age of onset is between 16 and 35 years, but 
retrospective studies have shown milder cognitive and psychopathological abnormalities 
during a prodromal period, which lasts on average for five years before the fully fledged 
clinical picture. Minor neurological and behavioural abnormalities can occur even earlier 
[129]. Core clinical symptoms include auditory hallucinations and bizarre delusions, illogical 
thinking and incoherent conversation, affective flattening, poverty of speech and lack of 
drive. The heritability has been estimated at around 50%, and genome-wide association 
studies have yielded the first replicated genetic risk variants [154]. Treatment with 
antipsychotic agents is often effective but only brings symptomatic relief. The observation 
that all antipsychotic agents are dopamine receptor antagonists has led to the dopamine 
hypothesis of schizophrenia. However, negative symptoms and cognitive deficits do not 
respond well, and therefore more research is needed into their mechanisms.  
Many current models ascribe schizophrenia to cortical circuit abnormalities resulting from 
the interplay of genetic risk factors and environmental influences [82, 134]. The models 
generally propose that dysfunctional coordination of distributed neural activity leads to the 
psychopathology and neuropsychology of schizophrenia. Cognitive deficits are often present 
before the onset of clinical symptoms. Working memory impairments, particularly in the 
visuospatial and verbal domain, are amongst the most consistent cognitive deficits in the 
schizophrenia prodrome. Prodromal patients perform about one standard deviation below the 
norm on standardised tests of working memory [193]. Furthermore, the magnitude of 
cognitive impairments following disease onset is associated with poor functioning and lower 
quality of life [72, 122]. Working memory deficits may in themselves lead to poorer outcome 
(for example because patients are cognitively less able to cope with psychotic symptoms) or 
they may reflect neurophysiological processes that lead to a more chronic course of 
schizophrenia. In either case, it will be important to identify the underlying 
neurophysiological mechanisms, and the hope is that these will inform future prevention and 
rehabilitation programmes.  
Working memory encompasses processes that form, maintain, and manipulate short-term 
representations, which are crucial for comprehension, learning, reasoning and many everyday 
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tasks [9]. The content of WM stores can be derived from sensory (e.g. visual, auditory, tactile 
etc.) information or internal processes (e.g. retrieving information from long-term memory). 
Due to its ubiquity WM has been selected as a promising measure to improve quality of life 
in schizophrenia (Cognitive Neuroscience Treatment Research to Improve Cognition in 
Schizophrenia, CNTRICS). WM spans a variety of processing levels (perceptual to cognitive) 
and is comprised of a number of component tasks. First, the information needs to be 
accurately perceived and encoded, second, the internal representation needs to be precisely 
maintained and defended against interference, and third it needs accurately to be compared 
with the relevant information in the probe. Additionally tasks may also involve the 
manipulation of items in WM (reordering of letters, spatial or object transformations) [e.g. 
146].  
Deficits in WM task performance can potentially arise from impairments in any of these 
phases irrespective of sensory modality or information source. In fact, patients with 
schizophrenia show deficits in fundamental processes during the early stages of sensory 
processing (e.g., lateral inhibition) up to deficits in higher cognitive processing in prefrontal 
areas. Nonetheless, many studies of WM impairments in schizophrenia have focussed on the 
later stages of processing (i.e. memory maintenance and retrieval) and particularly the 
contribution of prefrontal cortex (PFC) dysfunction. This bias is attributable both to the well 
documented physiological effects of schizophrenia on PFC function and Goldman-Rakic‟ 
[66] highly influential theory regarding the importance of the DLPFC in WM, which suggests 
that the sustained delay-period activity of neurons in PFC provides a neurophysiological 
substrate of the storage buffer proposed by the standard WM cognitive model [9]. Although 
this approach has been extremely fruitful it is becoming increasingly apparent that it cannot 
account for all empirical findings and that other approaches are needed [164]. Indeed, due to 
the traditional disciplinary divisions, executive and perceptual dysfunctions in patients with 
schizophrenia have largely been studied separately. In this review we argue that the study of 
visual working memory (WM) provides a natural opportunity for bridging the gap between 
these approaches because it inherently involves basic sensory and higher strategic processes. 
However, it is important to emphasise that WM deficits in schizophrenia have been reported 
from a wide variety of tasks that span across modalities some of the mechanisms described 
within the current review may apply quite generally across domains.  
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Neurophysiological and functional neuroimaging studies of visual WM in normal participants 
emphasise its dependence upon an extended network of neural areas including the prefrontal, 
parietal, primary and higher sensory cortices [133, 242]. For example, Pasternak and 
Greenlee [159] emphasise the nature of early (visual) areas contributing to WM. Importantly, 
areas within the WM network may be differentially associated with the various components 
of WM processing, but there may also be considerable interactions between areas 
contributing to these component processes. For example, top-down processes may contribute 
to the fidelity of visual representation during encoding.  
In recent years there has been considerable interest in the dynamics of network interactions 
through analysis of functional connectivity and the time course of network activity. One 
proposed mechanism is that functional networks are created transiently by the 
synchronisation of periodic firing of groups of neurons (termed oscillatory activity) within 
and between cortical areas [194, 195, 225]. Oscillatory activity has been shown to occur at a 
wide range of temporal frequencies (3 to over 100 Hz) and associated with a variety of 
cognitive functions [194]. These include a number of processes likely to be critical for WM 
performance including visual perception, object recognition, attention and memory 
maintenance [98, 208].  
This raises the possibility that abnormalities in synchronous oscillatory activity [121, 218] 
may provide a parsimonious account for many of the cognitive deficits observed in 
schizophrenia [163]. This is in line with the observation that the pathological process in 
schizophrenia does not respect regional (and functional) boundaries. For example, Selemon et 
al. [188] reported post-mortem changes in regions as widespread and functionally diverse as 
the primary visual and prefrontal cortices in schizophrenia [188]. As a consequence a number 
of researcher propose that core aspects of the pathophysiology of the disorder arise from a 
dysfunction in the integration and coordination of distributed neural activity [4, 57, 163]. This 
disconnection hypothesis is supported by reports of altered functional connectivity in 
schizophrenia during WM particularly between prefrontal and parietal areas [104, 144, 212] 
which indicates that perceptual deficits may in part result from impairments in reciprocal 
interactions between sensory and higher cortical areas [54]. Our own recent results confirm 
the important contribution of early visual processes to successful WM performance in healthy 
subjects and deficits in patients with schizophrenia [76, 77].  
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Nonetheless, only a few studies investigating WM impairment in schizophrenia have 
addressed the effects of early perceptual encoding problems or the interaction between 
sensory and prefrontal processing. This is surprising given the evidence (i) for patients‟ 
deficits in basic sensory processing [27, 28, 34, 94] for review), (ii) impaired encoding as a 
major contributor to WM deficits [120] and (iii) the link between WM and sensory processes 
[159]. Additionally, impairments in both perception and WM have been associated with 
deficits in synchronous oscillatory activity [14, 29, 76, 115, 132, 200, 219, 239] and at the 
neurochemical level both are associated with an imbalance between excitatory and inhibitory 
transmitters (glutamate and GABA) [130, 134]. The fractionation of working memory 
functions in the study of neurocognitive mechanisms of schizophrenia is also important for 
the molecular genetics approach. Working memory, like schizophrenia, has a heritability of 
about 50%, and some genetic variants have been implicated as risk factors for both 
schizophrenia and working memory dysfunction. Examples include genes for proteins 
involved in neurodevelopment, neurotransmission and neuroplasticity such as catechol-O-
methyltransferase, dysbindin-1 and neuregulin-1. Any genetic variant, unless it affected 
neuronal functioning so severely as to lead to global cognitive impairment, will only act on 
one or several of the component processes of WM, but not affect them indiscriminately. 
Thus, a better understanding of the physiology of the perceptual and executive processes 
needed for working memory will also aid the translation of genetic research. Studies on 
perceptual [43] and working memory [42, 233] effects of variations in the dysbindin-1 gene 
are a case in point. 
 
 
------------------------------------------------------------------------------------------------------ 
Figure 1 about here 
----------------------------------------------------------------------------------------------------- 
 
The current review will argue that WM deficits in schizophrenia can be best understood by 
considering the interactions of distributed neural populations associated with a variety of 
underlying cognitive processes. A distinctive pattern of molecular changes in subpopulations 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
8 
 
of neurotransmitter receptors and other synaptic proteins create abnormalities in cortical 
networks that underlie the core perceptual and cognitive deficits contributing to WM 
dysfunctions (Fig. 1). We will argue that synchronous oscillatory activity dynamically 
instantiates networks of neural activity and provides a substrate for linking WM deficits in 
schizophrenia across behavioural, neurophysiological, neurochemical and genetic levels. 
Synchronous oscillatory activity may be considered an intermediate phenotype or 
endophenotype, which are more closely correlated with the fundamental abnormalities 
underlying schizophrenia than the cognitive and behavioural symptoms themselves. 
 
Perceptual and encoding deficits contributing to WM in schizophrenia 
The earliest stages of WM involve extracting the critical information from a transient sensory 
input to form a more durable WM representation. This necessitates a variety of processes, 
collectively described under the term encoding, which if impaired can potentially contribute 
to impaired WM performance. Since the first evidence of WM impairments in patients with 
schizophrenia [158], several behavioural studies have shown impairments associated with 
WM encoding performance [60, 95, 120, 123], but the underlying causes remain to be fully 
understood.  
A WM encoding deficit may be attributable to documented disturbances in basic visual 
processing in schizophrenia. In a number of studies Butler et al. [25, 27, 94 for review] have 
provided evidence for a specific impairment in the magnocellular pathway. This is a visual 
pathway which specialises in the processing of luminance information, while chromatic 
information is subserved by parvo- and koniocellular pathways [112]. Interestingly, the rapid 
and transient signal transmission in the magnocellular pathway makes it ideal for quick links 
between early visual and higher cognitive areas. In fact, recent models of visual perception 
posit that the efficiency and speed of everyday vision largely rely on early bottom-up/top-
down interactions between occipital and prefrontal areas of the cortex which are driven by 
magnocellular projections from early visual areas [12, 114]. As a consequence magnocellular 
pathway deficits might contribute to encoding problems by causing basic difficulties in 
perceptual discriminability or top-down enhancement of earlier representations. Further 
fundamental perceptual difficulties that might affect WM have been reported by Dakin et al 
[34]. They showed that individuals with schizophrenia are less prone to the visual „contrast–
contrast‟ illusion (Fig. 2), which suggests that they have weaker visual contextual suppression 
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resulting from impaired lateral inhibition. This might result in difficulties encoding stimuli 
into WM due to either reduced perceptual salience or increased interference from competing 
stimuli. However, the consequences of these very basic effects on WM encoding have not 
been considered.  
 
------------------------------------------------------------------------------------------------------ 
Figure 2 about here 
----------------------------------------------------------------------------------------------------- 
 
Patients‟ WM performance may improve with increasing stimulus presentation duration or 
decreasing sensory discrimination thresholds, which points to an underlying encoding 
problem [8, 83, 123, 213]. Tek et al. [213] demonstrated that impaired perceptual processing 
in schizophrenia patients contributes to visuospatial working memory deficits. Patients 
showed impaired performance compared to controls for both an object and spatial perceptual 
discrimination task. The authors then adjusted the target exposure duration for participants to 
reach 80-90% performance on the task and used these stimuli in a working memory task 
where either the object or location had to be matched. After controlling for the perceptual 
performance patients still showed impaired performance for the spatial but not the object 
working memory task. These results suggest that both perceptual impairments and 
maintenance processes contribute to WM impairments in patients. Hartman et al. [83] asked 
participants to encode a set of 3 colours as part of a delayed match to sample task. They first 
adjusted stimulus presentation time to reach 80% correct performance level under a 0-delay 
condition for all participants. Patients needed longer stimulus presentation times to achieve 
such a performance level. However, there was no group difference in the delay conditions. 
These studies support the view that slowed or impaired visual processing may contribute to 
WM deficits, and that they can be remediated by longer presentation times or presentation at 
higher contrast.  
Visual WM is generally considered to comprise an initial iconic representation [202], from 
which critical information is extracted and consolidated for longer durations [100] into a low-
capacity visual short-term memory [137, 162, see 196 for an intermediate vSTM]. Visual 
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iconic memory is a high-capacity, but rapidly decaying (after approx. 100 ms) memory trace, 
more or less like a fleeting (and degraded) internal snapshot [202]. In contrast, short-term 
visual memory contains a more abstract representation [162] held for a brief time span and 
either consolidated for retention [165] or not retained. Elements seem to be transferred from 
this store sequentially [162], and its limited capacity of around four [137] means that many 
details are not encoded. Importantly, both iconic and short-term memory can be driven by 
low level perceptual processes as well being subject to the effects of strategic and other 
attentional factors [64, 120]. 
Results from studies investigating iconic and short-term memory in patients with 
schizophrenia have been mixed. Backward masking tasks have been used to investigate 
iconic memory formation. Presenting a mask within the first 100 ms following stimulus 
presentation supposedly interrupts processing within iconic memory, whereas presenting 
masks at longer intervals affects short-term memory. Patients typically show deficits in 
backward masking with mask presentations within 100 ms of stimulus presentation [20, 70, 
176]. This has usually been interpreted as an indication of a slow transfer from iconic to 
vSTM under the assumption that stimulus duration without a mask would be unchanged 
[153]. Knight et al. [107] have questioned the specificity of masks used to probe iconic 
memory. They argue that patients may impose meaning upon random pattern masks and 
consequently their disruptive effects may not be restricted to iconic processing, but instead 
may be found in more cognitive processing of representations into short-term memory. The 
authors compared patients‟ and controls‟ performance for masks that were either meaningless 
random patterns or real world photographs (cognitive mask). Although controls showed 
greatest interference for the cognitive mask, patients were equally affected by both, and the 
magnitude of the effect was similar to that of the cognitive mask in controls. In addition, 
Green and Walker [71] suggested that masking interrupts stimulus classification processes 
and that the masking deficit in patients with schizophrenia may reflect a slowing in the 
classification process. Hahn et al. [81] investigated whether patients‟ iconic memory was 
subject to a faster decay rate than that of controls. The authors used a partial report procedure, 
where patients had to memorise up to six letters arranged in a circle with a variable delay 
interval until a cue appeared indicating the target. Patients showed a similar decay rate to 
controls and the speed of cue processing and attention shifting was also unimpaired. 
Consequently Hahn et al [81] concluded that although the decay of iconic memory is normal 
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with patients with schizophrenia, it remains to be investigated whether there is a deficit in the 
formation of iconic memory. 
Several studies have argued that patients have a deficit in short term visual memory, but not 
in the iconic store [107, 168, 238]. One argument is that patients‟ performance is more 
disrupted than that of controls by masks presented at longer intervals [59, 60]. In these 
studies patients with schizophrenia were vulnerable to interference from mask for an 
abnormally prolonged duration, providing evidence for impaired WM consolidation into a 
more durable representation. Wynn et al. [238] used the attentional blink (AB) paradigm to 
dissociate masking effects at early (iconic) and later (STM) stages. They found that patients 
exhibited prolonged AB compared to controls, but that varying the mask strength specifically 
to target iconic representations had little effect on the patients‟ performance (no interaction 
between the groups). Thus the authors concluded that the abnormalities are specifically owed 
to deficits in short-term memory. However, the extent to which AB changes in schizophrenia 
are owed to perceptual masking or problems in selective attention has not been determined.  
WM encoding deficits may in principle arise from impairments in attention. Specifically, 
attention is important for the selection and transfer of task-relevant perceptual representations 
into WM. In particular patients may find it difficult to selectively encode task-relevant 
information and gate access to WM storage [64, 136]. However, attentional modulation of 
WM seems to be at least partially preserved in patients. In five change detection task 
experiments Gold et al. [64] demonstrated that patients with schizophrenia are able to use 
selective attention to guide WM encoding (this included both bottom-up and top-down cues 
for a subset of the stimuli and the ability to select these for WM encoding). These findings do 
not support a generalised attentional deficit, but there may still be specific impairments, e.g. 
whenever tasks require a high degree of top down control and rule selection. Patients with 
schizophrenia are consistently impaired in cognitive control (i.e. the ability to adjust 
strategies flexibly in accordance with one‟s intentions and goals) and n-back paradigms [see 
for instance 65, 136 for reviews]. In a N-back task participants are typically required to 
monitor a series of numbers or letters and to respond whenever a stimulus occurs that is the 
same as the one presented 1 or 2 trials previously (1 or 2 N-back). However, these tasks 
conflate the different stages of WM and thus make it difficult to assess their specific affects 
on encoding.  
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In summary, patients with schizophrenia exhibit fundamental perceptual deficits as well as 
higher level cognitive impairments. As a consequence patients exhibit deficits in encoding 
sensory information into WM. It is unclear whether initial iconic representations are affected, 
but there is good evidence for impairment in short-term memory. Furthermore, studies have 
indicated that although not generally impaired, bottom-up and top-down attentional processes 
can modulate (both positively and negatively) the encoding process in patients. To further 
understand the nature of these encoding deficits it is necessary to elucidate the underlying 
neurophysiological mechanisms. The available evidence for both perceptual and higher level 
contribution to WM encoding processes suggests that they are likely to require coordinated 
contribution from a network of processing areas. In the next section we will review whether 
impaired neural synchrony (as an index of network activity) may provide a parsimonious 
explanation for deficits during WM encoding.  
Synchronous oscillatory activity during cognitive tasks  
To form networks for any cognitive task it is necessary to link together the activity of groups 
of neurons involved in that particular task. There is a considerable body of evidence 
supporting the hypothesis that functional networks may be instantiated by groups of neurons 
repeatedly synchronising their firing at different frequencies in time [195, 225]. This elegant 
proposal enables neurons to flexibly contribute to many different networks implementing a 
variety of cognitive tasks. Synchronous oscillatory activity can be measured in a broad range 
of frequencies (theta: 3-7 Hz; alpha: 8-12 Hz, beta: 12-30 Hz, gamma: >30 Hz) by examining 
power and phase on a trial by trial basis. The last decade has demonstrated that such 
measures are related to a multitude of cognitive tasks including working memory and a 
variety of processes which may contribute to WM, e.g. feature binding in perception, object 
representation and attention [e.g. 6, 23, 38, 39, 52, 53, 74, 86, 90, 97, 99, 101, 105, 116, 138, 
140, 156, 157, 171, 194, 208-210, 220]. There is considerable evidence that synchronous 
oscillatory activity is impaired in schizophrenia and its widespread functional significance 
may provide a neurophysiological mechanism to help explain the range of deficits 
demonstrated by patients in WM tasks.  
Theorists distinguish between three main forms of synchronized oscillatory activity: evoked 
activity, induced activity and long-range synchrony. Evoked oscillatory activity is tightly 
time and phase-locked to the onset of the stimulus and has been especially related to early, 
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stimulus-driven encoding processes, which is commonly measured by averaging the response 
across all trials and then examining power in a specific frequency band. It can also be 
measured by examining the variability in the phase of a stimulus elicited response at a 
specific electrode across individual trials (termed inter-trial phase locking or inter-trial 
coherence (ITC)).  
Although induced activity is also elicited in direct response to the appearance of the stimulus 
its timing reflects internal network processes and is therefore less tightly linked to stimulus 
onset, which is commonly measured by examining the power in each frequency band for 
individual trials and then averaging this power across trials1. Finally, long-range synchrony 
measures phase coupling between electrodes, which reflects the degree to which activity at 
those sites form part of a common functional network of activity. In general long-rang 
synchrony is considered to depend upon coordination in the lower frequency ranges (theta, 
alpha, beta) [185, 226] because synchronization at lower frequencies tolerates longer 
conduction delays [108] necessary for forming temporal synchronised networks over large 
distances. All these forms of synchronised oscillatory activity provide mechanisms to 
integrate neural activities that instantiate the stable, salient and coherent representations 
required for WM even when information is no longer available in the environment [98]. 
Additionally, they provide mechanisms for understanding the fundamental basis of WM 
processes.  
The relationship between synchronised oscillations at different frequencies has been 
proposed to explain WM capacity limitations. More specifically, Lisman and Idiart [135] 
used computer simulations to demonstrate that working memory capacity can in principle be 
explained by the number of gamma cycles (where each cycle represents an individual 
memory item) per theta cycle. Subsequent physiological studies provided evidence to support 
such a relationship between memory capacity and activity in the gamma and theta frequency 
range [5, 182]. Axmacher et al [5] showed that cross-frequency coupling between the phase 
of the theta activity and gamma band amplitude in the human hippocampus accompanies 
                                                          
1
 Following the recent report of Yuval-Greenberg et al ([243] S. Yuval-Greenberg, O. Tomer, A. Keren, I. Nelken, L. Deouell, 
Transient induced gamma-band response in EEG as a manifestation of miniature saccades., Neuron 58 (2008) 429-441. see also 
[142] L. Melloni, C. Schwiedrzik, M. Wibral, E. Rodriguez, W. Singer, Response to: Yuval-Greenberg et al., "Transient 
Induced Gamma-Band Response in EEG as a Manifestation of Miniature Saccades." Neuron 58, 429-441., Neuron 62 (2009) 8-10; 
author reply 10-12.), the possibility of a relationship between induced gamma band activity and microsaccades should also be 
considered. 
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WM maintenance of multiple items. Importantly, a recent physiological study has 
demonstrated that the order and segregation of items may be encoded by the phase of the 
theta wave in relation to each gamma peak [189, see 223 for comment].  
A recent study has attempted to understand the dynamic functions of the entire WM 
network by examining synchronised oscillatory activity across the whole of the cortex during 
the performance of a delayed discrimination task, which enabled segregation of the distinct 
processes underlying WM [156]. They concluded that the maintenance of object 
representations in WM is implemented by interareal phase synchrony in the alpha, beta and 
gamma band -frequency bands within and between fronto-parietal and visual areas. 
In summary, synchronized oscillatory activity provides a mechanism for dynamic 
formation of networks during cognitive tasks. More specifically, the interaction of oscillatory 
activity across different frequencies may be the missing (physiological) link between the 
processes underlying WM and may explain the limitations in WM capacity. In the next 
section we review the evidence that patients with schizophrenia exhibit impairments in 
oscillatory activity during a variety of cognitive tasks associated with WM.  
 
Abnormal Neural Synchronisation in Schizophrenia and Working Memory 
Recent models of cognitive deficits and a substantial body of findings from EEG 
studies have emphasized the potential role of neural synchrony as a pathophysiological 
mechanism underlying impaired perceptual [e.g. 132, 200, 219] and cognitive processes [e.g. 
7, 14, 29, 76, 184], which may consequently explain deficits across processes associated with 
WM [79].  
Evidence for early visual deficits in synchronised oscillatory activity have been 
provided by studies investigating steady-state response, visual binding and object 
representation and backward masking [see 218 for a recent review]. Visual steady-state 
evoked potential (SSVEP) paradigms are used to probe the ability of cortical networks to 
generate and maintain oscillatory activity in patients with schizophrenia. A stimulus is 
flickered at a specific temporal frequency and modulates neural activity in early visual areas 
to produce the SSVEPs. These are synchronized to the flicker in frequency and phase. 
Krishnan et al. [111] showed significantly reduced SSVEPs in patients with schizophrenia 
compared to controls at high (17 Hz, 23 Hz, and 30 Hz) but not at low flicker frequencies. 
This result is consistent with the large number of studies reporting that patients with 
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schizophrenia have a specific deficit in the magnocellular pathway [e.g. 26, 183, but see 
Skottun BC, Skoyles J. for an alternative view], which is associated with high temporal 
frequency visual responses. Furthermore, Butler et al. [25, 28] demonstrated a correlation 
between impaired SSVEP generation and reduced integrity of the optic radiation in patients 
with schizophrenia.  
There is also evidence for reduced evoked oscillatory activity in response to stable 
non-flickering visual stimuli [200, 201, 219]. Spencer et al. [200] examined responses to 
illusory Kanizsa triangles, which evoked gamma frequency oscillations and a high-degree of 
inter-trial phase locking at electrodes associated with visual processing in healthy 
participants, but these responses were considerably attenuated in patients. Finally, patients 
show reduced evoked [239] and induced [73] gamma band oscillations in response to 
backward visual masking. In comparison to controls patients showed a specific deficit in 
evoked gamma-band activity for masked targets but not unmasked targets.  
Steady-state evoked potentials can also be elicited by periodic auditory stimulation. 
Light et al. [132] showed impairments at 30 and 40 Hz for the auditory steady state response 
and demonstrated and an association with reduced working memory performance (measured 
with the Letter-Number Sequencing test). This suggests that deficits at early sensory-
perceptual stages of processing may contribute to WM encoding difficulties across sensory 
modalities. A more global deficit in thalamocortical projections, perhaps mediated through 
dysfunction in one of the key neurotransmitter systems (glutamatergic, GABAergic, 
cholinergic) may thus underlie these impairments in stimulus-driven oscillations. However, 
reduced gamma oscillations in schizophrenia are not confined to situations where the 
oscillations are driven by external stimuli (and reduced power could thus be an effect of 
impaired sensory input channels), but also occurred with direct transcranial cortical 
stimulation [50].  
In a recent series of studies we have directly examined the effects of WM encoding 
deficits in schizophrenia, which are assumed to arise in large part due to the visual processing 
difficulties described above. We first measured neural activity with event-related potentials 
(ERPs) during WM encoding of up to three abstract test shapes that were presented 
sequentially and followed by a probe shape, which was either drawn from the test shapes 
(50%) or was a non match (a visual delayed discrimination task). For control participants, but 
not patients, a prominent early P100 (related to stimulus encoding) increased with WM load 
and predicted performance (Fig. 3A). Furthermore, the P100 reduction in patients was 
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mirrored by reduced activation of visual areas in fMRI [77]. A reduced P100 during WM 
encoding has recently also been reported in participants with high schizotypy compared to 
low schizoptypy [109]. Together with the P100 reduction observed in relatives of patients 
with schizophrenia these results point to a role of such neurophysiological changes as trait 
markers of schizophrenia, or indeed of a psychosis spectrum [32], considering that similar 
effects have also been reported in bipolar disorder [240]. 
 
------------------------------------------------------------------------------------------------------ 
Figure 3 about here 
 
One possible explanation for this P100 deficit is an increase in neuronal response 
variability (“cortical noise”) in patients. This would lead to a higher trial to trial variation of 
the P100 response and thus the average would be reduced compared to controls. In a 
subsequent paper we examined these deficits in patients with schizophrenia in greater detail 
by looking at the effects of oscillatory activity in a broad frequency range. We demonstrated 
that patients show reduced evoked theta, alpha, and beta oscillatory activity during WM 
encoding [76] (Fig.3B). Importantly, in contrast to ERPs and evoked oscillatory activity, 
induced oscillatory activity can be used to assess directly the processes occurring during the 
maintenance period. In our study, induced gamma activity increased monotonically across all 
tested loads in controls, but reached an asymptote at load 2 in patients, reflecting a greater 
impact of task difficulty in patients.  
Although most neurophysiological studies of cognitive tasks in patient groups focus 
on the mechanisms of cognitive deficit, it is of equal interest to investigate the mechanisms 
that support the cognitive abilities that are preserved or provide some compensation. One 
possibility is that patients use selective attention to enhance the salience of items to be 
encoded into WM, because this function is largely unaffected in patients with schizophrenia 
[64, 65]. Consistent with this proposal we recently demonstrated that alpha phase-locking 
during encoding correlates with working memory performance in patients (but not controls) 
[78]; activity in this frequency band has been linked to selective visual attention [214, 234].  
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Interestingly, physiological evidence from animal models indicates that attention can 
directly enhance the temporal precision with which networks of oscillatory activity are 
formed [117] and suggests a physiological mechanism for its putative compensatory role in 
the above studies. Furthermore, Lakatos et al [117] link the specific pattern of evoked and 
phase reset responses to the specific (parvalbumin-expressing neurons) and nonspecific 
(calbindin expressing neurons) thalamocortical pathways, respectively. Given that mainly the 
former have been related to deficits in oscillatory activity in schizophrenia [130], this may 
further support the notion that some subprocesses of WM are preserved (see below for 
details). In summary, oscillatory activity can be used to identify both the impaired 
components of the WM network and the compensatory mechanisms.  
Several studies have now shown abnormal oscillatory activity in response to working 
memory and executive function in schizophrenia [14, 29]. There is also evidence from animal 
models of schizophrenia for reduced prefrontal-hippocampal synchronization as a substrate 
for impaired working memory [190]. 
In addition to the delayed discrimination studies described above that looked at the 
different component processes separately, there are a few studies that investigated the 
relationship between reduced oscillatory activity and tasks that require a high degree of top 
down control [136] such as N-back paradigms and other tasks involving executive function 
[14, 29, 184]. For example, Cho et al. [29] used a stimulus-response compatibility task where 
patients with schizophrenia showed a higher behavioral cost for incongruent compared to 
congruent trials. Controls, but not patients, showed increased induced gamma band activity 
for the incongruent condition, which correlated with performance. The authors linked this 
induced gamma band activity to the need to override the automatic pre-potent response. This 
aspect of cognitive control was impaired in the patients, which could be explained by the 
reduced oscillatory activity.  
Basar-Eroglu et al. [14] and Schmiedt et al. [184] used an N-back task in which the 
stimuli were selected from three possible numbers. In addition they manipulated demands on 
executive function by having one number require a response with the opposing hand. In 
conditions requiring high cognitive control (respond with opposing hand) they found evoked 
frontal theta (not apparent in other conditions) and evoked gamma activity that increased with 
WM load in the healthy participants. In contrast, patients with schizophrenia showed 
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attenuated evoked theta activity and high gamma band activity but neither increased with 
WM load.  
In addition to these studies, which focused on impairments in measures of power, 
there is also EEG and some MEG evidence for impairments in functional connectivity during 
WM tasks. Measures of functional connectivity in neural networks can be obtained through 
correlation analysis [160] or graph theory [15, 36, 145, 155]. Networks with “small-world 
properties” are characterised by a combination of local clustering of activity and a short 
characteristic path length as an index of global integration and cost efficiency. Patients with 
schizophrenia exhibited dysfunctional organization of neuronal networks during WM. Bassett 
et al [15] used small-world properties to demonstrate that working memory performance in 
the N-back task was associated with greater cost efficiency in the beta frequency band in 
controls than in patients with schizophrenia, indicating cortical inefficiency within these 
networks. In addition to reduced efficiency, De Vico Fallani et al. [36] also reported an 
increase in cortical synchronization in the high alpha (11-13 Hz) frequency range in a group 
of high functioning patients with schizophrenia who were able to perform the N-back task as 
well as controls, which was interpreted as a compensatory mechanism (see also Haenschel et 
al., 2010 for findings of relationship between alpha phase locking and performance in 
patients with schizophrenia).  
In summary, the reviewed studies suggest a relationship between impairments in 
synchronized oscillatory activity and perceptual and higher-level cognitive processing 
contributing to WM deficits in schizophrenia. Additionally, correlations in synchronized 
activity and performance may also indicate the use of compensatory mechanisms to perform 
the task, e.g. increased alpha phase locking as an indicator of increased attention. In the next 
section we review the evidence for a link between impairments in oscillatory activity and 
neurotransmitter dysfunctions.  
 
 
Neuropharmacological mechanisms underlying WM and oscillatory activity 
Contemporary models understand WM dysfunctions as a result of cortical circuit 
abnormalities. One way of gaining insights into the neural circuits in which the WM 
dysfunction is embedded it to investigate the actions and interaction of neurotransmitters 
involved in the disorder [16, 134]. The relationship between the dopaminergic, GABAergic, 
glutamatergic and cholinergic systems and WM has long been established. Both animal and 
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human studies [170] also point to effects on WM-related brain activation. However, we only 
start to understand the relationship between these neurotransmitters and impaired oscillatory 
activity contributing to WM deficits.  
 
Dopamine 
First evidence for a relationship between neuromodulators and WM came from a study 
showing that dopamine depletion in the monkey DLPFC markedly impaired WM [22]. 
Sawaguchi & Goldman-Rakic [179] reported selective impairment of working memory 
(delayed saccades) after local infusion of D1, but not D2 antagonists; further studies showed 
that response-related but not mnemonic activation is D2 receptor-dependent [228], which 
provides insight into the specific pharmacology of WM subprocesses. [179, 180]. Because 
administration of dopaminergic drugs in humans has not consistently resulted in memory 
improvement, it is likely that any WM-enhancing effects of dopamine will depend on the 
specific receptor and postsynaptic signaling cascade and/or the homoestatic state of 
dopamine. Regarding the latter, it has been proposed that dopamine promotes cognitive 
function during hypodopaminergic states but can disrupt it during hyperdopaminergic states. 
Functional polymorphisms of genes related to the dopamine system may provide a non-
invasive way of measuring these states. For example, the Val(108/158)Met polymorphism on 
the gene for catechol-O-methyltransferase (COMT), a dopamine-degrading enzyme, 
influences dopamine concentration. Val-carriers, who have reduced prefrontal dopamine 
levels, show slightly reduced performance on the n-back WM task [211] and higher noise 
levels in prefrontal activity, measured by ERPs [232]. These effects may interact with genetic 
variants that influence the concentration of postsynaptic dopamine receptors [203]. Such 
interactions may explain why low intrinsic dopamine levels alone are not sufficient for 
dopaminergic medication to enhance working memory. A recent study on emotional face 
working memory in Parkinson‟s disease found changing emotion biases (from sad to angry) 
after dopaminergic medication, but no overall improvement [206in revision]. Furthermore, 
recent evidence for epistatic effects between variants on the genes for the dopamine D2 
receptor and the alpha-4 subunit of the nicotinic acetylcholine receptor on WM capacity at 
higher WM loads suggests an interplay of multiple neuromodulatory systems [139]. 
 
It has further been suggested that dopamine/D1 signaling modulates the cortical signal-to-
noise ratio by enhancing selective inputs to both pyramidal cells and inhibitory interneurons 
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[67] and it has been shown that reduced D1-receptor signaling on prefrontal pyramidal cells 
attenuates GABAA and NMDA- receptor induced currents [45, 186, 187]. Dopamine may 
thus modulate frequency-dependent signal transmission and thereby adjust oscillations in 
cortical networks [91]. Recent evidence for the importance of dopaminergic modulation of 
parietal in addition to prefrontal areas [141] suggests that similar mechanisms may also apply 
to other parts of the cortical WM. Dopaminergic input can have inhibitory or excitatory 
effects on pyramidal neurons, depending on which group of dopamine receptors (D2, D3, D4 
or D1, D5) are activated, and thus may reduce or enhance oscillatory activity. A study of the 
effects of functional polymorphisms in the dopamine transporter and D4 receptor genes has 
provided first EEG evidence for such divergence [40], but further receptor-specific studies 
are needed to determine the direction of the effects of dopamine on gamma oscillations.  
Dopamine modulates glutamatergic and GABAergic transmission, and is also under 
the influence of the same synaptic proteins. Dystrobrevin-binding protein-1 (dysbindin-1) 
regulates both dopamine and glutamate release and trafficking. Genetic variability in 
dysbindin-1 contributed to interindividual differences in spatial working memory in 
schizophrenia patients [42] and in working memory for emotional faces in healthy controls 
[233]. The neurophysiological effects of dysbindin-1 variants have been investigated with 
both early/ perceptual ERPs (P100) [43] and indices of (prefrontal) cognitive control [48]. 
These findings underline the importance of looking beyond the classical neurotransmitter 
pathways of synthesis, release, receptor binding, transport and degradation and assess 
functional differences in the synaptic apparatus, which is likely to be crucial for the 
maintenance of oscillatory activity as well.  
 
GABA 
The work on the link between dopamine and WM was later complemented by studies 
showing that in monkeys‟ activity of gamma-aminobutyric acid (GABA) neurons in DLPFC 
are essential for normal WM function [169, 181]. Interestingly, this work was based on 
previous results showing that GABAA mediated inhibition plays an important role in the 
generation of spatial selectivity in the primary sensory areas of cortex. For instance, in the 
primary visual cortex both broadening of orientation tuning [47, 178, 191] and reduction of 
directional selectivity [151] have been observed with the application of bicuculline 
methiodide, a GABAA receptor antagonist. Rao et al. [169] showed that GABAA mediated 
inhibition plays an important role at the cellular level in the processes underlying spatial 
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working memory in the dPFC as well, improving spatial selectivity and possibly playing 
critical roles in the attentional control mechanisms of central executive function. 
Interestingly, Yoon et al. [241] showed a reduced GABA concentration in visual cortex in 
patients with schizophrenia. They found a correlation with GABA concentration and 
orientation-specific surround suppression as further evidence for impaired lateral inhibition 
[34] and thus a deficit in early visual processing.  
GABAergic inhibition has also been functionally linked to the generation of cortical 
oscillations within different frequency bands [130, 134, 217, 231]. For instance, gamma band 
oscillations can be produced and propagated intracortically by network interactions among 
large groups of inhibitory and excitatory neurons. These networks consist of interconnected 
inhibitory interneurons that are coupled to each other and shaped into a rhythmic pattern 
through their mutual connections. When this network of inhibitory neurons is tonically 
excited by excitatory pyramidal neurons, the interneurons entrain each other and impose a 
synchronised inhibition across the population. When the synchronised inhibition decays, the 
neurons will enable and determine when a pyramidal cell to which they project will fire 
[231]. In summary the inhibitory network receives a steady tonic drive, which makes the 
network oscillate. It is thus providing a clock, which determines when pyramidal cells can 
fire, if they receive suprathreshold, excitatory afferent inputs (Jefferys, Traub & Whittington, 
1996) and thus generates oscillation in different frequency bands.  
Inhibition from subclasses of GABA neurons has been shown to be important for 
synchronised oscillatory activity. For instance, whereas selective activation of the 
interneurons containing the Ca2+-binding protein parvalbumin (PV) is sufficient to generate 
gamma oscillations in mice in vivo [197], the multipolar GABA neurons that express both 
PV and calbindin may give rise to theta frequency (4–7 Hz) oscillations [19]. 
Muthukumaraswamy et al. [152] provided further support for a relationship between GABA 
concentration and gamma band frequency. The authors showed a correlation between the 
individual gamma frequency and the GABA concentration measured in visual cortex with 
MR-spectroscopy [46, 152].  
PV neurons are characterized by a fast-spiking pattern and control the excitability of 
pyramidal neurons [58]. The release of GABA from PV neurons is controlled by the growth 
factor neuregulin 1 (NRG1) through its ErbB4 receptor. Selective ablation of these receptors 
in mice resulted in a phenotype with schizophrenia-like features, including impaired working 
memory, reduced pre-pulse inhibition and hyperactivity. Some of these features normalized 
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after treatment with diazepam, a positive allosteric modulator of the GABAA receptor. Thus, 
reduced GABAergic activity can lead to schizophrenia-like phenotypes in experimental 
animals. It is interesting that both the NRG1 and the ErbB4 gene have been suggested to be 
susceptibility genes for schizophrenia [13, 229].  
In ErbB4 knockout mice both the number of PV-interneurons and induced gamma 
oscillations have been shown to be reduced [51]. Furthermore, blocking GABAA receptors 
alters the dynamic profile of gamma oscillatory activity to changes in the network drive [216, 
231]. Genetically modified mice, in which GABAA receptor-mediated synaptic inhibition 
onto PV-interneurons was removed exclusively, exhibited altered theta oscillations and 
altered coupling between theta and gamma oscillations [235]. In contrast, gamma oscillations 
were not changed, indicating that mutual inhibition between PV interneurons is not necessary 
for the generation of oscillations in this frequency range [68 for review, 235].  
However, a direct link between alterations in glutamatergic (using ketamine) onto 
GABAergic neurotransmission and gamma oscillatory activity has been found in animal 
models of schizophrenia [33, 174], demonstrating a deficit in rhythmogenesis. It has therefore 
been suggested that the abnormalities of GABAergic networks in schizophrenic patients may 
lead to reduced oscillatory activity and thus to WM deficits.  
Thus it is not surprising that alterations in the GABA system have been suggested to 
underlie WM deficits. Several studies have suggested alterations of the GABA system in the 
brains of patients with schizophrenia [17, 126, 130] providing evidence of a dysfunction of 
inhibitory interneurons in schizophrenia (Fig. 4). Postmortem studies have shown that the 67-
kiloDalton isoform of glutamic acid decarboxylase (GAD67) responsible for the synthesis of 
GABA is reduced in patients with schizophrenia [224]. In general, the GABAergic system is 
vulnerable to changes and can be modified by a variety of factors [246]. For instance, there is 
some evidence that GAD67 can be reduced by sensory deprivation [31, 84].  
Using network simulation Vierling-Classen et al. [222] showed that increasing the 
time the decay time at the GABAA synapse from interneuron to pyramidal neuron can model 
the gamma band deficits found in schizophrenia. Increasing the decay time of the extended 
inhibitory postsynaptic current (IPSCs) resulted in longer inhibition and a reduced probability 
of pyramidal cell spiking for a longer duration. As expected from these simulations, patients 
showed pronounced 20 Hz (beta band), but reduced 40 Hz activity in an auditory steady state 
paradigm. Interestingly, these authors noted that the fidelity of the networks is not only 
dependent on the GABAergic interneurons, but also on the strength of the drive of the input 
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to the network. If the drive is too strong, it will overrule any extended inhibition. This raises 
the question whether a sufficiently salient or motivating stimulus may also be enough to 
overcome extended inhibition and enhance weak synchronization, in this instance the 
diminished gamma activity. 
Finally, it has been proposed that WM impairments in schizophrenia might be 
improved with GABAA agonists [130]. The suggestion is that these drugs may alleviate WM 
dysfunctions by increasing the synchronization of pyramidal cell firing at gamma frequencies 
attributable to an enhancement of the chandelier neuron inhibition of DLPFC pyramidal 
neurons [131]. Indeed, there is now some evidence that MK-0777, a relatively selective 
agonist at GABAA receptors containing α2 subunits, improves performance in a cognitive 
control task and increases the power of gamma band oscillations in individuals with 
schizophrenia [127]. Lewis et al. note that “the adverse cognitive effects and sedation 
associated with the benzodiazepines currently available (which are attributable to their 
activity at GABAA receptors containing alpha1 and alpha5 subunits) are likely to mask the 
hypothesized cognitive benefits associated with alpha2 selectivity”. 
In addition GABAB receptor activity may also be impaired in schizophrenia. GABAB 
receptor agonists such as baclofen had ameliorating effects in several animal models of 
schizophrenia. Using a paired pulse TMS paradigm Daskalakis et al. [35] combined 
interleaved transcranial magnetic stimulation and EEG to measure long interval cortical 
inhibition, which has been suggested to be related to GABAB receptor mediated 
neutransmission [177]. They first reported a selective inhibition of DLPFC (middle frontal 
gyrus) but not of motor cortex in healthy participants and now extended this finding by 
reporting that patients with schizophrenia exhibit deficits in inhibition of DLPFC [49, see 
also 50]. In summary, both deficits in inhibition (both GABAA & B) may result in a lack of 
precision that is necessary to ensure multiple item coding by specific phase codes and thus 
disrupt the functional connectivity necessary to ensure functioning of the WM network. 
 
NMDA 
Evidence for an involvement of N-methyl-d-aspartate (NMDA) receptor activity in WM has 
come from studies with NMDA receptor antagonists in rats [221]. A study that applied an 
NMDA receptor antagonist directly to the DLPFC also reported impaired working memory 
performance in monkeys [44]. A role for NMDA receptor activity in schizophrenia is based 
on the finding that NMDA antagonists, such as ketamine or Phencyclidine (PCP), mimic both 
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positive and negative symptoms of schizophrenia [96]. The NMDA receptor has consistently 
been related to the cognitive symptoms of schizophrenia. Several studies investigated the 
effects of acute ketamine on different aspects of working memory tasks [147]. NMDA 
receptor antagonists have been shown to disrupt encoding processes [30] and to have an 
effect on manipulation but not on maintenance in frontal-parietal regions measured with 
fMRI [88]. Furthermore, in an N-back study ketamine was associated with decreased scores 
on the one-back and two-back, but not the zero-back condition [2, 148], indicating stronger 
effects with higher WM loads.  
NMDA receptors play a crucial role in neuronal communication. Blocking NMDA 
does not only interfere with excitatory transmission and synaptic plasticity, but it also reduces 
the drive to inhibitory interneurons [230] (see Figure 3). Several recent studies demonstrate 
that altered GABA neurotransmission may be secondary to abnormalities in NMDA receptor 
functioning [87, 246]. This is based on the finding that ketamine reduces the activity of 
GABA interneurons and thus disinbibits pyramidal neurons [75]. In addition to the effect of 
acute intake, chronic ketamine intake has been shown to result in a reduction in the number 
of parvalbumin-containing axoaxonic cartridges (see Fig 4). These are synaptic terminals of 
inhibitory chandelier cells [149]. The reduced input on parvalbumin- containing interneurons 
(indicating low pyramidal activity) have been suggested to not only reduce parvalbumin, but 
to also downregulate GAD67, the principal synthesizing enzyme for GABA [149, 246]. This 
can be seen as an maladaptive attempt to restore pyramidal cell activity to the correct levels 
[134]. Taken together, these abnormalities may interfere with the generation of oscillatory 
activity and may lead to the observed changes in schizophrenia. 
 
 
------------------------------------------------------------------------------------------------------ 
Figure 4 about here 
 
There is evidence both from in vivo recordings from mouse hippocampus [119] and 
from human EEG [89] using the auditory paired-click gating paradigm that ketamine 
increases gamma oscillatory activity and reduces slow frequency activity. Interestingly, Hong 
et al. [89] showed that the increase in gamma and decrease in delta frequency predicted 
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withdrawal–retardation symptoms measured using the Brief Psychiatric Rating Scale (BPRS) 
directly following the EEG recording. 
There is however in-vitro evidence for reduced oscillatory high-frequency activity in 
response to ketamine as well, which fits better with the cellular models of interneuron 
inhibition discussed above [33, 41, 174]. Roopun et al. [174] showed that ketamine can have 
region-specific effects with an increase in gamma in one region and reduced or no effect in a 
different region. They argued that reduced power in one region may lead to phase delays 
between oscillating networks across the cortex and as a consequence changes in long-range 
synchrony may occur. In addition, this would explain a reduction in lower frequencies, but 
also an increase in phase variability. Any of these changes may result or contribute to WM 
deficits in schizophrenia. These results emphasize the importance of understanding the time 
course of differential contributions of areas comprising the WM-network.  
Alternatively, differential effects of acute or chronic ketamine have to be taken into 
account when using this as a model for schizophrenia [see 89, 166]. Whereas acute ketamine 
augments glutamate concentration measured with MR-spectroscopy in humans [175], it is the 
chronic use of ketamine that results in NMDA receptor hypofunction. Indeed, glutamate 
concentration has been shown to be higher in patients with recent onset of schizophrenia [24] 
but reduced in chronic schizophrenia [215].  
Chrobak et al [30] tested the effects of ketamine on the encoding, retrieval and 
retention of memory in a delayed-match-to-place radial water maze task and showed 
impairment in encoding of new location information because of an increase of proactive 
interference. The authors suggested that the strength of the encoded representation is 
weakened with ketamine administration, which is in line with previous results of 
hippocampal place cells [103]. They also suggest that ketamine produces changes in theta and 
gamma power and coherence and that it decouples the phase relationship between the two 
frequencies, which may contribute to reduced WM capacity found in individuals with 
schizophrenia.  
In addition to the abnormalities of excitatory NMDA-receptor transmission on 
shaping the inhibitory GABAergic transmission, these functional impairments may also 
interact with structural abnormalities [21], such as reductions in amount of cortical neuropil, 
axon terminals and dentritic spines density on cortical pyramidal neurons in schizophrenia 
[62, 126]. Dendritic spines are the principal targets of excitatory synapses to pyramidal 
neurons. These abnormalities have mainly been found in deep layer 3 pyramidal neurons in 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
26 
 
DLPFC and other areas as well [126], which suggests an involvement in primarily 
intracortical circuits, and thus recurrent excitation [199]. This is in line with the 
dysconnection theory, according to which reduced synaptic connectivity results in abnormal 
functional integration of neural systems [57, see 204 for a recent review]. Furthermore, 
Friston (1999) suggested that this would be compatible with deficient backward modulatory 
connections given that backward (top-down) connections are slow, modulatory (voltage-
sensitive NMDA receptor dependent) and divergent (less topographically specific) [10, see 
review in 56]. Reductions in spine density reflecting reduced network connectivity would 
provide an explanation for the impairments in long-range synchrony and could contribute to 
deficits in WM network functioning.  
 
Cholinergic system 
 
Finally, there is some suggestion that abnormalities in the cholinergic system may also 
contribute to the WM deficits [92, 113]. The involvement of the cholinergic system in 
schizophrenia has been suggested by the extremely high prevalence of smoking in patients 
with schizophrenia and by the clinical observation that patients use smoking as self-
medication for symptom relief. Nicotine transiently improves ERP indices (the repetition 
positivity, [see 80] of stimulus encoding and sensory memory trace formation in a auditory 
roving oddball paradigm [11], performance and related fMRI activity in a rapid visual 
information processing task [118] and performance in the N-back task [113] in healthy 
smokers and nonsmokers. Furthermore, in patients with schizophrenia nicotine normalizes 
the auditory sensory gating (P50) deficit [3] that has been specifically related to alterations in 
the α7 nicotinic receptor, improves deficits in spatial WM [124], sustained attention [125] 
and performance in the N-back task [92]. Jacobsen et al. [92] also demonstrated that in line 
with performance improvement, nicotine also enhanced activity of and functional 
connectivity between brain regions involved in WM using fMRI in schizophrenia. 
Evidence is starting to emerge that can explain these network functions. The α7 
nicotinic receptors are concentrated on interneurons [110] and, by enhancing the excitation of 
the GABAergic interneurons, they may enhance their inhibitory output [134, 227]. Indeed, 
nicotine increases the gamma oscillations that are dependent on interneuron function in rat 
hippocampal slices [198]. Furthermore, cholinergic modulation (mainly via muscarinic 
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receptors) has also been shown to increase and to stabilize oscillatory activity [172, 173], 
which is not surprising given their role in attention [37].  
Interestingly, animal studies have shown that oscillatory activity can be increased by 
stimulation of the mesencephalic reticular formation [85, 150], which triggers increased 
levels of ACh in the cortex [207], and by direct cholinergic stimulation [173]. In addition, 
stimulation of the nucleus basalis of Meynert, the main source of cortical ACh, also induced 
high-frequency oscillations [143]. Moreover, stimulation of the mesopontine cholinergic 
nuclei in the brainstem that activate processes in thalamocortical systems also facilitated 
oscillatory activity [205]. 
Thus alterations in the cholinergic system seem to contribute to deficits in oscillatory 
activity. It of interest to note that Gallinat et al. [61] tested the effect of smoking in patients 
and found higher early gamma activity in response to targets in an auditory oddball paradigm 
in smokers compared to non-smokers. Given that the α7 nicotinic receptor functioning has 
been shown to be impaired in schizophrenia; it is not surprising that patients can benefit from 
nicotine in some domains. Both the α7 and the α4/β2 receptor subtype are involved in 
working memory, at least in animal models [124].  
Deco & Thiele [37] speculate that acetylcholine may increase the representation of 
stimuli that are within the current attentional focus, and protects it against interference from 
competing stimuli, thus resulting in reduced distractibility. In line with this there is some 
evidence that ACh can increase the signal-to-noise ratio of neural activity [192], reduce spike 
frequency adaptation (i.e., a gradual reduction of the firing frequency) and increase the 
efficacy of feedforward input [63] by acting on presynaptic nicotinic receptors located on 
thalamocortical synapses [167].  
 
Conclusions and future research: 
Working memory dysfunction is a core feature of schizophrenia, which many 
previous studies have linked to prefrontal cortex (PFC) dysfunction affecting memory 
maintenance and retrieval. In the current review we have argued that WM performance 
results from a range of processes implemented across many cortical areas, and that 
disturbances in any of these component processes or their interactions may contribute to 
impaired performance. Additionally, we have claimed that patients‟ residual performance 
may result from the recruitment of additional mechanisms to perform WM tasks. The review 
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has focused upon visual WM as an exemplar system, and we have emphasized the 
importance of early perceptual and encoding processes. We gave two main reasons for this: 1. 
the ability to encode stimuli into WM inherently acts as a limiting factor upon WM and, thus, 
impairments in this process will affect performance. 2. Understanding the links between 
impairments in neurochemical and system level processes in sensory areas is likely to 
contribute to understanding abnormalities at higher levels. Current models suggest that a 
distinctive pattern of molecular changes in neurotransmitter systems creates abnormalities in 
cortical network that underlie the core perceptual and cognitive deficits contributing to WM 
dysfunctions [for instance 134].  
The review has focused upon the role of synchronized oscillatory activity as a bridge 
between basic neurochemical impairments and consequent performance deficits. The current 
evidence indicates that dysfunctional coordination of distributed neural activity associated 
with a variety of perceptual and cognitive functions leads to WM deficits in schizophrenia. 
These dysfunctions arise from impairments in a wide range of frequencies and associated 
processes. Importantly, correlations between WM performance and synchronous oscillatory 
activity can also identify the operation of compensatory mechanisms recruited by patients to 
perform tasks, e.g. the correlation between alpha phase locking and patients‟ performance 
indicating increased use of attention relative to controls. Recent methodological 
developments will help to further clarify the dynamic interactions of perceptual and executive 
processing areas contributing to working memory. For instance dynamic causal modeling 
(DCM) can be used to measure the strength and direction of connectivity between neural 
ensembles [55, 161], which will reveal the time-course of these interacting processes. 
Furthermore, combining measures of oscillatory activity and functional and structural fMRI 
[244, 245] will further elucidate the relationship between reductions in grey and white matter 
and impairments in oscillatory activity. 
As noted earlier, synchronous oscillatory activity provides not only a window into 
working memory dysfunctions in schizophrenia but also a method by which in vivo, in vitro 
and computer simulation studies can be usefully combined. Measures of neuronal synchrony 
have been defined for both human and animal electrophysiology and can be studied at various 
levels of spatial analysis, from microscopic (e.g., single-unit recordings) to macroscopic (e.g., 
EEG) measurements [195, 220]. As a consequence they are uniquely suited for the testing of 
models of schizophrenia from molecular through to behavioural levels. Additionally, 
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oscillatory activity provides a powerful tool for examining the effects of translational 
research into the treatment of cognitive dysfunction in schizophrenia by illuminating the 
effects on the underlying neural mechanisms a basis for the development of biologically 
motivated animal models.  
Understanding the relationship between neurochemical processes and oscillatory 
activity has resulted in the development of new pharmacological models developed in vitro. 
For instance, there is now some evidence that improving signaling through GABAA receptors 
containing an α2 subunit ameliorates working memory impairments and enhances gamma 
band oscillations associated with the specific cognitive task employed [127]. Furthermore, 
the link between oscillations and neurochemistry provides an important area for extending 
existing models. For example, the work by Javitt and colleagues demonstrating that deficits 
induced by NMDA antagonists can be reversed by compounds such as d-serine or glycine 
transport inhibitors that stimulate NMDA function [93, 102] is likely to be reflected in 
changes in oscillatory activity.  
Recent methodological advances offer the opportunity to understand the relationship 
between neurochemical and neurophysiological processes in vivo. Specifically, measures of 
neurotransmitter concentration using magnetic resonance spectroscopy (MRS)2 can be 
combined with EEG/MEG recordings of oscillatory activity. For instance, the specific 
frequency of oscillatory activity (measured using MEG) has been linked to the magnitude of 
GABA concentration in the visual cortex [46, 152]. Furthermore, the GABA concentration in 
visual cortex has now also been shown to be reduced in individuals with schizophrenia [241].  
The links between neurochemical and system level processing, outlined in the studies above, 
offer an important potential future line of research for understanding very recent advances in 
the development of targeted behavioural therapies for cognitive deficits. Several studies have 
shown that WM can be improved by extensive adaptive training [106]. Training may target 
strategic processes, which the participant consciously adapts, or automatically induce plastic 
changes in the WM-network through repetitive activation. Furthermore, WM-training has 
                                                          
2
 MRS relies on detecting resonance properties of the hydrogen atoms in the molecule of 
interest (GABA, but also glutamate (Glu), glutamine) exposed to magnetic fields in a specific 
area measured in an MRI-scanner. 
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been linked to neurochemical changes in dopamine [141]. Of particular relevance for the 
current review, behavioural training programmes have been shown to produce improvements 
in WM for patients with schizophrenia. For instance, Adcock & Vinogradov [1] developed an 
adaptive auditory WM training programme demonstrating improvements in both early 
perceptual processing (perception and speech reception) and auditory working memory 
capacity [see also 18 for perceptual training effects on WM]. A broader cognitive remediation 
therapy (CRT) has also been associated with moderate improvements in digit span [236, 
237]. Understanding the neural basis of the changes induced by these therapies using 
oscillatory activity may facilitate the development of further therapies that more effectively 
target the underlying impairments. Furthermore, the evidence for compensatory mechanisms 
in patients may open up new strategies for therapies for example by enhancing the 
compensatory mechanism utilized by patients rather than trying to restore deficient processes. 
Finally, understanding the links between neurochemical processes, oscillatory and 
behavioural impairments may enable us to differentiate between the underlying bases of 
cognitive problems in different disorders. Although WM deficits are common to many 
neurological and mental disorders, as well as healthy ageing, it is unlikely that the underlying 
pathology is the same. This is important because it affects the likely consequences of 
different treatment strategies.  
In summary, WM is critical for many day to day activities and is comprised of a wide 
range of underlying processes which are instantiated by coordinated activity across the brain. 
Synchronous oscillatory activity provides a basis for studying the processes and linking 
behaviour to underlying neurophysiological and neurochemical mechanisms. Future 
improvements in techniques for measuring neurochemical changes and oscillatory activity 
offer considerable opportunities for targeting therapies to enhance WM performance in 
schizophrenia and other neuropsychiatric disorders.  
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Legend 
Figure 1. This figure illustrates the hierarchical relationship between different processing 
levels in the brain from genes to behaviour. Considerable insight into working memory and 
its dysfunction in disorders like schizophrenia can result from combining understanding 
gained at different levels in the processing hierarchy. The systems approach provides a bridge 
between behaviour and molecular mechanisms. 
Figure 2. The medium-contrast disk in the centre of the figure is physically identical to the 
outer-disk at the bottom (labelled “True match”), but most normal participants are unable to 
ignore the high-contrast surround and match to a much lower contrast (e.g. the disk labelled 
“Typical match”). Dakin et al [34] showed in this experiment that patients with schizophrenia 
are generally much more accurate (i.e. immune to the illusion). Patients are more likely to 
match it to the “true match”. With permission taken from 
http://www.ucl.ac.uk/~smgxscd/ClinicalResearch.html.  
Figure 3. Fig. 3A depicts the P100 (P1) ERP component at the central occipital electrode 
(Oz) for each memory load for controls (CT, top) and patients with early-onset schizophrenia 
(SZ, bottom).  The different WM loads are denoted by the line colour (black for load 1, green 
for load 2 and red for load 3). Fig. 3B shows the power of evoked oscillatory activity at theta 
(θ, top), alpha (α, middle), and beta (β, bottom) frequencies during working memory (WM) 
encoding for both groups at WM load 1. For each frequency the figure depicts the power for 
each group over time (up to 3s) and a line graph comparing the controls (blue) and patients 
(red). Modified from [76, 77]. 
Figure 4: Top: Parvalbumin (PV)-containing inhibitory interneurons modulate levels of 
excitatory activity via release of GABA to pyramidal neurons (excitatory neuron). The PV-
containing neurons (for example chandelier cells) are themselves regulated by glutamatergic 
input, for example through NMDA receptors. In controls, the inhibitory neuron maintains 
sufficient GABA release and the excitatory neuron sufficient glutamate release to balance 
inhibition with excitation. The feedback inhibition generates gamma oscillations. Bottom: In 
individuals with schizophrenia, decreased NMDA receptor signalling alters the monitoring 
function of the inhibitory neuron, which down regulates its output, disinhibiting the 
excitatory neuron. This process is compounded by reductions in GABA-related proteins. 
Altered GABA neurotransmission by PV-containing neurons is indicated by PV reductions, 
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reduced GAD 67 (GABA synthesis), a decrease in GAT1 (GABA membrane transporter) 
expression and an upregulation of GABAA receptor α2-subunit at the pyramidal neurons 
(enlarged circle). [Modified from 69, 128, 134]. 
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